155 related articles for article (PubMed ID: 34485511)
1. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C
Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511
[TBL] [Abstract][Full Text] [Related]
2.
Liao L; Duan D; Liu Y; Chen L
Cell Cycle; 2020 Jul; 19(14):1846-1854. PubMed ID: 32578511
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
Tian Z; Yu T; Wei H; Ning N
J Clin Lab Anal; 2020 Feb; 34(2):e23071. PubMed ID: 31693242
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor LHPP suppresses cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cell lines.
Ma L; Sun H; Xu X; Chen Y; Zhang L; Li S; Tang L
J Physiol Biochem; 2022 Nov; 78(4):807-817. PubMed ID: 35796893
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
7. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
[TBL] [Abstract][Full Text] [Related]
9. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract][Full Text] [Related]
10. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma.
Lin YH; Wu MH; Huang YH; Yeh CT; Lin KH
Cells; 2020 Jan; 9(2):. PubMed ID: 31973032
[TBL] [Abstract][Full Text] [Related]
11. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
12. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
13. Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.
Zhu X; Qi G; Li C; Bei C; Tan C; Zhang Y; Shi W; Zeng W; Kong J; Fu Y; Tan S
DNA Cell Biol; 2019 Feb; 38(2):193-197. PubMed ID: 30562063
[TBL] [Abstract][Full Text] [Related]
14. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
15. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
16. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
[TBL] [Abstract][Full Text] [Related]
17. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
[TBL] [Abstract][Full Text] [Related]
18. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
Xie C; Wu J; Yun J; Lai J; Yuan Y; Gao Z; Li M; Li J; Song L
PLoS One; 2013; 8(5):e64235. PubMed ID: 23717574
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
[TBL] [Abstract][Full Text] [Related]
20. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Saito S; Ojima H; Ichikawa H; Hirohashi S; Kondo T
Cancer Sci; 2008 Dec; 99(12):2402-9. PubMed ID: 19038010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]